Fazia Mana

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Autoimmune Disease, Immunosuppressive Therapy, Immunology +5

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht et al. · Gastroenterology · 2018 · 295 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Infliximab Dose +8

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

Martine De Vos, Édouard Louis, Jørgen Jahnsen et al. · Inflammatory Bowel Diseases · 2013 · 202 citations · Full text

Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12‐Month Results of a Prospective Multicenter Study

Guy‐Bernard Cadière, Michel Buset, Vinciane Muls et al. · World Journal of Surgery · 2008 · 157 citations · Full text

Patient and staff exposure during endoscopic retrograde cholangiopancreatography

Nico Buls, J Pages, Fazia Mana et al. · British Journal of Radiology · 2002 · 99 citations

Engineering, Radiation Exposure, Gastroenterology +18